Search review questions

Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, defined by anatomic (structural) criteriad · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, defined by anatomic (structural) criteriab · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Patient‐reported outcome at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Mean change in the number of glaucoma medications at the longest · people with primary open‐angle glaucoma or ocular hypertension

Need for additional treatment at the longest · people with primary open‐angle glaucoma or ocular hypertension

Glaucoma progression at 12 months, measured by additional visual field defects · people with primary open‐angle glaucoma or ocular hypertension

Change in pain intensity from baseline to 1 month · children and adults with corneal abrasion

Recurrent corneal erosion within 1 year · children and adults with corneal abrasion

Change in visual acuity from baseline to 1 year, or loss of 1 or more lines of best‐corrected visual acuity at 1 month · children and adults with corneal abrasion

Quality of life at 1 month · children and adults with corneal abrasion

Proportion of participants achieving a 2‐line improvement in visual acuity (Snellen chart) (higher scores indicate better vision) · NIIPPU

Proportion of participants with confirmed macular edema (lower number of events is better) · NIIPPU

Proportion of participants achieving a 2‐line improvement in visual acuity (Snellen chart) (higher scores indicate better vision) Â · NIIPPU

Proportion of participants with confirmed macular edema (lower number of events is better) · NIIPPU

Proportion of participants achieving steroid‐sparing control (higher number of events is better) · NIIPPU

Proportion of participants achieving a 2‐line improvement in visual acuity (Snellen chart) (higher scores indicate better vision) · NIIPPU

Adverse effect: new cataract formation · people with dry eye

Change in patient‐reported quality of life scores · people with dry eye

Change in patient‐reported quality of life scores · people with dry eye

Stereoacuity at distance Loss of ≥ 2 octaves near stereoacuity, measured using the Preschool Randot test 3 years after surgery · people with intermittent exotropia, aged less than 11 years

Motor fusion test · people with intermittent exotropia, aged less than 11 years

Minor adverse events Defined as any adverse event within 8 weeks of surgery that does not require further intervention · people with intermittent exotropia, aged less than 11 years

Quality of life measures Measured at 3 years using the IXTQ scores for children, parents, or parent proxies (i.e. parents' perception of their children's quality of life). Scores could range from 0 (worst quality of life) to 100 (best quality of l... · people with intermittent exotropia, aged less than 11 years

Motor alignment at near fixation Measured using PACT at 6 months · people with intermittent exotropia, aged 5 to 49 years

Stereoacuity at near · people with intermittent exotropia, aged 5 to 49 years

Stereoacuity at distance Measured using the Preschool Randot test 3 years after surgery · people with intermittent exotropia, aged 5 to 49 years

Motor alignment at distance fixation Measured using PACT at 6 months · people with intermittent exotropia, aged 5 to 49 years